M. Vreeburg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Vreeburg has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Maurice Adrianus Monique van Steensel
Lee Kong Chian School of Medicine, Nanyang Technological University, Republic of Singapore
2 shared publications - Michel van Geel
Department of Dermatology, Maastricht UMC+ Centre of Expertise for Genodermatoses, Maastricht University Medical Centre+ , Maastricht
2 shared publications - Alexander P. A. Stegmann
Maastricht University Medical Center+, Maastricht, NL
1 shared publication C.T.R.M. Schrander‐Stumpel
GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands
1 shared publicationD. Marcus‐Soekarman
Department of Clinical Genetics
1 shared publication- Frank van Leersum
Department of Dermatology Maastricht University Medical Center Maastricht The Netherlands
1 shared publication
Latest Publications
- Open Access
- 22 June 2019
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 14 (1) , 1-4
Schnitzler’s syndrome - a novel hypothesis of a shared pathophysiologic mechanism with Waldenström’s disease
Schnitzler’s syndrome is an auto-inflammatory disorder which is characterized by two mandatory features: an urticarial rash and a monoclonal gammopathy. Although the pathophysiology of this syndrome is not yet fully understood, a role for interleukin-1 seems apparent. While this presumed link between interleukin-1 and the monoclonal gammopathy is not yet elucidated, a mutual factor in pathophysiology however seems likely. Here we present a novel hypothesis of a shared pathophysiologic mechanism between Schitzler’s syndrome and monoclonal gammopathy.
- 22 June 2019
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 14 (1) , 1-4
Open AccessSchnitzler’s syndrome - a novel hypothesis of a shared pathophysiologic mechanism with Waldenström’s disease
Schnitzler’s syndrome is an auto-inflammatory disorder which is characterized by two mandatory features: an urticarial rash and a monoclonal gammopathy. Although the pathophysiology of this syndrome is not yet fully understood, a role for interleukin-1 seems apparent. While this presumed link between interleukin-1 and the monoclonal gammopathy is not yet elucidated, a mutual factor in pathophysiology however seems likely. Here we present a novel hypothesis of a shared pathophysiologic mechanism between Schitzler’s syndrome and monoclonal gammopathy.
- 11 April 2013
- Published by Wiley in Clinical Genetics
- Vol. 85 (4) , 328-335
Cutaneous clues for diagnosing X‐chromosomal disorders
In a multidisciplinary outpatient clinic for hereditary skin diseases and/or syndromes involving the skin, 7% (30 of 409) of patients were found to have an abnormality involving the X chromosome, a mutation in a gene located on the X chromosome or a clinical diagnosis of an X‐linked monogenetic condition. The collaboration of a dermatologist and a clinical geneticist proves to be very valuable in recognizing and diagnosing these conditions. By combining their specific expertize in counselling an individual patient, X‐linked diagnoses were recognized and could be confirmed by molecular and/or cytogenetic studies in 24 of 30 cases. Mosaicism plays an important role in many X‐linked hereditary skin disorders. From our experience, we extracted clinical clues for specialists working in the field of genetics and/or dermatology for considering X‐linked disorders involving the skin.
- 11 April 2013
- Published by Wiley in Clinical Genetics
- Vol. 85 (4) , 328-335
Cutaneous clues for diagnosing X‐chromosomal disorders
In a multidisciplinary outpatient clinic for hereditary skin diseases and/or syndromes involving the skin, 7% (30 of 409) of patients were found to have an abnormality involving the X chromosome, a mutation in a gene located on the X chromosome or a clinical diagnosis of an X‐linked monogenetic condition. The collaboration of a dermatologist and a clinical geneticist proves to be very valuable in recognizing and diagnosing these conditions. By combining their specific expertize in counselling an individual patient, X‐linked diagnoses were recognized and could be confirmed by molecular and/or cytogenetic studies in 24 of 30 cases. Mosaicism plays an important role in many X‐linked hereditary skin disorders. From our experience, we extracted clinical clues for specialists working in the field of genetics and/or dermatology for considering X‐linked disorders involving the skin.
- 15 April 2011
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 25 (5) , 592-595
Focal dermal hypoplasia in a male patient due to mosaicism for a novel PORCN single nucleotide deletion
Focal dermal hypoplasia (FDH) is an X-linked dominant disorder caused by nonsense mutations and deletions in the PORCN gene coding for a transmembrane endoplasmic reticulum protein required for Wingless signalling. Symptoms consist mainly of linear atrophic skin defects, skeletal deformities and, in many cases, mental retardation. Osteopathia striata is a nearly constant feature. Approximately 90% of patients are women. A few instances of father-to-daughter transmission and a number of sporadic male cases presumably as a result of somatic mosaicism have been recorded. The aim of this study was to demonstrate the presence of somatic mosaicism for PORCN mutations in a male patient. We sequenced the PORCN gene in different tissues from a boy with symptoms of FDH. We demonstrate post-zygotic mosaicism for a novel deletion in the PORCN gene. A novel PORCN deletion, present in a post-zygotic mosaic, causes focal dermal hyplasia in a male patient.
- 15 April 2011
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 25 (5) , 592-595
Focal dermal hypoplasia in a male patient due to mosaicism for a novel PORCN single nucleotide deletion
Focal dermal hypoplasia (FDH) is an X-linked dominant disorder caused by nonsense mutations and deletions in the PORCN gene coding for a transmembrane endoplasmic reticulum protein required for Wingless signalling. Symptoms consist mainly of linear atrophic skin defects, skeletal deformities and, in many cases, mental retardation. Osteopathia striata is a nearly constant feature. Approximately 90% of patients are women. A few instances of father-to-daughter transmission and a number of sporadic male cases presumably as a result of somatic mosaicism have been recorded. The aim of this study was to demonstrate the presence of somatic mosaicism for PORCN mutations in a male patient. We sequenced the PORCN gene in different tissues from a boy with symptoms of FDH. We demonstrate post-zygotic mosaicism for a novel deletion in the PORCN gene. A novel PORCN deletion, present in a post-zygotic mosaic, causes focal dermal hyplasia in a male patient.